Observational studyESMO open2024

Real-world treatment patterns and outcomes in patients with HR+/HER2- metastatic breast cancer treated with chemotherapy in the United States.

S M Tolaney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.